AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2022
Aug 30, 2022
34395_dirs_2022-08-30_2d3b5bb4-28a5-47c5-9766-b59b8dda7d43.zip
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-08-30-05:00
Reporting Person: Reynolds Cameron John (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-30-05:00 | Common Stock | P | 3500 | $1.61 | Acquired | 1195518 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1007718 | Indirect |
| Common Stock | 34076 | Indirect |
Footnotes
F1: The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.